Cost-effectiveness of Alternative Approaches to Hepatitis C Diagnosis and Treatment Initiation for Treatment-naive People Who Inject Drugs in Australia: A Model-based Economic Evaluation - Takeaways - MDSpire

Cost-effectiveness of Alternative Approaches to Hepatitis C Diagnosis and Treatment Initiation for Treatment-naive People Who Inject Drugs in Australia: A Model-based Economic Evaluation

  • By

  • Christopher R Bailie

  • Nick Scott

  • Alisa E Pedrana

  • Margaret E Hellard

  • Joseph S Doyle

  • August 22, 2025

  • 0 min

Share

  • 1

    The study evaluated cost-effectiveness of seven hepatitis C diagnosis and treatment strategies for treatment-naive individuals who inject drugs in Australia.

  • 2

    Reflex laboratory antibody then RNA testing was the most cost-effective strategy, reducing average cost per treatment completion to $6141 AUD.

  • 3

    Point-of-care testing strategies improved treatment initiation but were more expensive, with costs ranging from $6976 to $11,707 AUD per completion.

  • 4

    Changes in treatment uptake of at least 16 points were necessary to equate reflex laboratory testing with point-of-care strategies.

  • 5

    The study highlights the need for innovative strategies to engage undiagnosed populations and optimize the hepatitis C care cascade.

Original Source(s)

Cost-effectiveness of Alternative Approaches to Hepatitis C Diagnosis and Treatment Initiation for Treatment-naive People Who Inject Drugs in Australia: A Model-based Economic Evaluation

  • by Christopher R Bailie, Nick Scott, Alisa E Pedrana, Margaret E Hellard, Joseph S Doyle

  • August 22, 2025

Related Content

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

The Journey to Hepatitis C Elimination in Taiwan: Insights From the Hemodialysis Population

Assessment of RNA at SVR4 and Treatment Completion as Alternative Measures of Hepatitis C Cure for People Who Inject Drugs